找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Lentiviral Vectors and Gene Therapy; David Escors,Karine Breckpot,Holly Stephenson Book 2012 The Author(s) 2012 cancer.clinical trial.gene

[复制链接]
查看: 51566|回复: 37
发表于 2025-3-21 17:10:48 | 显示全部楼层 |阅读模式
书目名称Lentiviral Vectors and Gene Therapy
编辑David Escors,Karine Breckpot,Holly Stephenson
视频video
概述Concise overview of the development of lentivectors and gene therapy, integrating historical facts, the development and experimental application of lentivectors.Ideal introduction and book of referenc
丛书名称SpringerBriefs in Biochemistry and Molecular Biology
图书封面Titlebook: Lentiviral Vectors and Gene Therapy;  David Escors,Karine Breckpot,Holly Stephenson Book 2012 The Author(s) 2012 cancer.clinical trial.gene
描述.Gene therapy was conceived during the early and mid part of the 20th century. At first, it was considered a revolutionary biomedical procedure, which could potentially cure any disease for which the molecular bases were understood. Since then, gene therapy has gone through many stages and has evolved from a nearly unrealistic perspective to a real life application. Clinical efficacy in humans was demonstrated at the beginning of this century after its successful application in small-scale clinical trials to cure severe immunodeficiency in children. However, their successes were overshadowed some time later by the occurrence of vector-related leukaemia in a number of treated children. It is in this context that lentiviral vectors have appeared, with improved efficiency and, possibly, increased biosafety. Very recently, the first clinical trials with lentivectors have been carried out with some success. .This Brief firstly defines gene therapy, and places lentivectors within this fascinating therapeutic strategy. Then follows a comprehensive description of the development of retroviral and lentiviral vectors and how to specifically target distinct cell types and tissues. The authors
出版日期Book 2012
关键词cancer; clinical trial; gene therapy; lentivector; promoter; viral immunology; genetic engineering
版次1
doihttps://doi.org/10.1007/978-3-0348-0402-8
isbn_softcover978-3-0348-0401-1
isbn_ebook978-3-0348-0402-8Series ISSN 2211-9353 Series E-ISSN 2211-9361
issn_series 2211-9353
copyrightThe Author(s) 2012
The information of publication is updating

书目名称Lentiviral Vectors and Gene Therapy影响因子(影响力)




书目名称Lentiviral Vectors and Gene Therapy影响因子(影响力)学科排名




书目名称Lentiviral Vectors and Gene Therapy网络公开度




书目名称Lentiviral Vectors and Gene Therapy网络公开度学科排名




书目名称Lentiviral Vectors and Gene Therapy被引频次




书目名称Lentiviral Vectors and Gene Therapy被引频次学科排名




书目名称Lentiviral Vectors and Gene Therapy年度引用




书目名称Lentiviral Vectors and Gene Therapy年度引用学科排名




书目名称Lentiviral Vectors and Gene Therapy读者反馈




书目名称Lentiviral Vectors and Gene Therapy读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:51:56 | 显示全部楼层
David Escors,Grazyna Kochan,Holly Stephenson,Karine Breckpotanguage. In this paper, we explore the use of Boogie as an intermediate verification language for verifying programs in Whiley. This is noteworthy because the Whiley language has (amongst other things) a rich type system with considerable potential for an impedance mismatch. We report that, whilst a
发表于 2025-3-22 03:30:20 | 显示全部楼层
发表于 2025-3-22 04:48:08 | 显示全部楼层
发表于 2025-3-22 09:07:08 | 显示全部楼层
Grazyna Kochan,David Escors,Holly Stephenson,Karine Breckpotanguage. In this paper, we explore the use of Boogie as an intermediate verification language for verifying programs in Whiley. This is noteworthy because the Whiley language has (amongst other things) a rich type system with considerable potential for an impedance mismatch. We report that, whilst a
发表于 2025-3-22 14:00:57 | 显示全部楼层
发表于 2025-3-22 20:09:57 | 显示全部楼层
发表于 2025-3-23 00:15:45 | 显示全部楼层
发表于 2025-3-23 01:49:25 | 显示全部楼层
Immunomodulation by Genetic Modification Using Lentiviral Vectors,immunization strategies are needed, especially for chronic infections or malignant diseases where immune responses must be reactivated. Lentivector gene therapy can offer an alternative to modulate immune responses.
发表于 2025-3-23 06:57:33 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-27 18:49
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表